CryoPort (CYRX)
(Delayed Data from NSDQ)
$16.23 USD
+0.12 (0.74%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $16.21 -0.02 (-0.12%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth D Momentum F VGM
Income Statements
Fiscal Year end for CryoPort, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 233 | 237 | 223 | 79 | 34 |
Cost Of Goods | 134 | 133 | 126 | 42 | 17 |
Gross Profit | 99 | 104 | 97 | 36 | 17 |
Selling & Adminstrative & Depr. & Amort Expenses | 214 | 136 | 114 | 66 | 35 |
Income After Depreciation & Amortization | -115 | -32 | -18 | -30 | -18 |
Non-Operating Income | 21 | 3 | -251 | 0 | 1 |
Interest Expense | 6 | 6 | 5 | 3 | 1 |
Pretax Income | -99 | -35 | -274 | -33 | -18 |
Income Taxes | 0 | 2 | 2 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -100 | -37 | -276 | -33 | -18 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -100 | -37 | -276 | -33 | -18 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -36 | -7 | 4 | -20 | -15 |
Depreciation & Amortization (Cash Flow) | 80 | 25 | 21 | 10 | 3 |
Income After Depreciation & Amortization | -115 | -32 | -18 | -30 | -18 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 48.74 | 48.99 | 45.93 | 38.58 | 33.39 |
Diluted EPS Before Non-Recurring Items | -1.41 | -0.87 | -1.85 | -0.84 | -0.55 |
Diluted Net EPS (GAAP) | -2.21 | -0.93 | -6.18 | -1.94 | -0.55 |
Fiscal Year end for CryoPort, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 57.26 | 56.16 | 57.02 | 62.82 |
Cost Of Goods | NA | 34.00 | 31.89 | 32.29 | 35.75 |
Gross Profit | NA | 23.26 | 24.27 | 24.73 | 27.07 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 93.13 | 41.17 | 43.06 | 37.12 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -69.87 | -16.90 | -18.33 | -10.05 |
Non-Operating Income | NA | 7.43 | 5.47 | 1.94 | 6.47 |
Interest Expense | NA | 1.31 | 1.36 | 1.33 | 1.51 |
Pretax Income | NA | -63.75 | -12.80 | -17.72 | -5.08 |
Income Taxes | NA | -1.36 | 0.47 | 0.64 | 0.49 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -62.39 | -13.27 | -18.36 | -5.57 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -62.39 | -13.27 | -18.36 | -5.57 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 48.97 | 48.90 | 48.71 | 48.36 |
Diluted EPS Before Non-Recurring Items | NA | -0.51 | -0.31 | -0.42 | -0.16 |
Diluted Net EPS (GAAP) | NA | -1.32 | -0.31 | -0.42 | -0.16 |